Global Neurovascular Stents Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

Neurovascular Stents Market Size

• The global neurovascular stents market size was valued at USD 1.39 billion in 2024 and is expected to reach USD 2.98 billion by 2032, at a CAGR of 10.00% during the forecast period
• The market growth is largely fueled by the increasing prevalence of neurovascular disorders such as strokes, aneurysms, and carotid artery disease, driving demand for advanced treatment options
• Furthermore, technological advancements in stent design, including drug-eluting and bioresorbable stents, are improving treatment efficacy and patient outcomes, boosting adoption in hospitals and specialized clinics

Neurovascular Stents Market Analysis

• Neurovascular stents, providing minimally invasive treatment options for conditions such as strokes, aneurysms, and carotid artery disease, are increasingly critical components of modern neurovascular interventions due to their effectiveness in restoring blood flow, reducing complications, and improving patient outcomes
• The escalating demand for neurovascular stents is primarily driven by the rising prevalence of neurovascular disorders, advancements in stent technology including intracranial and carotid artery stents and growing awareness among physicians and patients about minimally invasive treatment options
• North America dominated the neurovascular stents market with the largest revenue share of 43% in 2024, supported by a high prevalence of neurovascular diseases, advanced healthcare infrastructure, favorable reimbursement policies, and the presence of leading market players such as Stryker and Boston Scientific, driving substantial adoption in hospitals and specialized neurovascular center
• Asia-Pacific is expected to be the fastest-growing region in the neurovascular stents market during the forecast period due to increasing healthcare expenditure, improving healthcare infrastructure, and rising demand for advanced treatment options in emerging economies such as China and India
• Intracranial stents dominated the neurovascular stents market with a share of 57.8% in 2024, driven by their wide application in treating cerebral aneurysms and stenosis, and increasing adoption in hospitals and medical centers for improved patient outcomes

Report Scope and Neurovascular Stents Market Segmentation       

Neurovascular Stents Market Trends

Advancements in Minimally Invasive Stent Technologies

• A significant and accelerating trend in the global neurovascular stents market is the development of advanced intracranial and carotid artery stents that allow minimally invasive treatment of strokes, aneurysms, and stenosis, improving patient outcomes and recovery times
  • For instance, flow-diverting intracranial stents enable precise placement in cerebral arteries, reducing the risk of complications while effectively treating complex aneurysms
• Innovations such as drug-eluting stents and bioresorbable materials are enhancing treatment efficacy by preventing restenosis and supporting vascular healing, which is increasing physician adoption
• The integration of stent delivery systems with imaging and navigation technologies allows for more accurate deployment and real-time monitoring during procedures, providing safer interventions
• This trend towards more sophisticated, patient-friendly, and clinically effective stents is reshaping treatment protocols and expectations, with companies such as Stryker and Boston Scientific leading in R&D of next-generation devices
• The demand for neurovascular stents that combine minimally invasive approaches with advanced materials and delivery systems is growing rapidly across hospitals and specialized medical centers, driven by improved clinical outcomes and procedural efficiency

Neurovascular Stents Market Dynamics

Driver

Increasing Prevalence of Neurovascular Disorders and Rising Awareness

• The growing incidence of strokes, cerebral aneurysms, and carotid artery disease worldwide is a significant driver for the rising demand for neurovascular stents
  • For instance, increasing awareness among physicians and patients regarding the benefits of minimally invasive interventions is promoting stent adoption in hospitals and medical centers
• Rising healthcare expenditure and favorable reimbursement policies in developed regions are facilitating access to advanced stent technologies and supporting market expansion
• In addition, the growing number of neurointerventional procedures, coupled with enhanced training for specialists, is boosting the uptake of innovative intracranial and carotid artery stents
• Expansion of specialized neurovascular centers in emerging economies is driving market growth by increasing access to advanced stent treatments in previously underserved regions
• Growing partnerships between device manufacturers and healthcare providers are facilitating training programs and clinical trials, which are enhancing market confidence and adoption rates
• The increasing focus on early diagnosis and timely intervention for neurovascular disorders is encouraging hospitals and ambulatory surgical centers to integrate advanced stent solutions into their treatment protocols

Restraint/Challenge

High Costs and Regulatory Compliance Hurdles

• The high cost of advanced neurovascular stents, including drug-eluting and bioresorbable variants, poses a significant barrier to adoption, particularly in developing regions with constrained healthcare budgets
  • For instance, small or mid-sized hospitals may delay procurement due to limited funding for expensive interventional devices, affecting market penetration
• Stringent regulatory requirements and lengthy approval processes in key markets such as the U.S. and Europe can slow the introduction of innovative stent products
• Furthermore, concerns regarding potential procedural complications and the need for specialized training for interventionalists can limit widespread adoption in smaller healthcare facilities
• Limited awareness and understanding of advanced stent technologies among healthcare providers in emerging markets can hinder market expansion, requiring educational initiatives and clinical support
• Competition from alternative treatment options such as coiling, thrombectomy devices, and medication therapy can restrict market share for neurovascular stents, necessitating continuous product innovation and clinical evidence to maintain adoption
• Addressing these challenges through cost optimization, streamlined regulatory pathways, and enhanced physician training programs will be crucial for sustained growth in the global neurovascular stents market

Neurovascular Stents Market Scope

The market is segmented on the basis of product type, material, and end-user.

• By Product Type

On the basis of product type, the neurovascular stents market is segmented into intracranial stents and carotid artery stents. The intracranial stents segment dominated the market with the largest revenue share of 57.8% in 2024, driven by their wide application in treating cerebral aneurysms and stenosis. These stents are highly preferred in hospitals and specialized neurovascular centers due to their minimally invasive nature, ability to navigate complex vasculature, and proven clinical efficacy. Intracranial stents also benefit from ongoing innovations such as drug-eluting coatings and flow-diversion technology, which enhance safety and patient outcomes. The increasing prevalence of strokes and aneurysms further supports their widespread adoption. Moreover, healthcare providers often prioritize intracranial stents due to their compatibility with advanced imaging systems, enabling precise deployment. Continuous physician training and awareness programs also contribute to the strong market presence of intracranial stents.

The carotid artery stents segment is expected to witness the fastest growth rate of 11.2% from 2025 to 2032, driven by rising cases of carotid artery disease and increasing awareness of minimally invasive interventions. Carotid stents reduce the risk of stroke compared to traditional surgical procedures and are increasingly adopted in both hospitals and ambulatory surgical centers. Growing reimbursement coverage and government initiatives promoting early intervention in vascular diseases further accelerate market expansion. In addition, technological advancements in stent flexibility and delivery systems make carotid artery stents safer and easier to deploy. The segment’s growth is also supported by rising geriatric populations and increasing screening programs for carotid artery stenosis.

• By Material

On the basis of material, the neurovascular stents market is segmented into metal, polymers, and others. The metal segment dominated the market with the largest share of 65.5% in 2024, owing to its superior mechanical strength, durability, and compatibility with complex neurovascular anatomies. Metal stents, often made of nitinol or cobalt-chromium alloys, provide reliable radial force and long-term patency, making them the preferred choice in hospitals and medical centers. Their established clinical track record and extensive use in both intracranial and carotid interventions support strong adoption. In addition, ongoing innovations such as thin-strut designs and enhanced biocompatibility further boost their demand. Metal stents also integrate well with imaging technologies, enabling precise deployment in delicate vascular regions. Physicians often prefer metal stents for high-risk or complex procedures due to their reliability and proven outcomes.

The polymer segment is expected to register the fastest CAGR of 12.4% during the forecast period, driven by the development of bioresorbable stents and polymer-coated devices. These stents offer temporary scaffolding and gradually dissolve, reducing long-term complications and enhancing vascular healing. Polymer stents are gaining traction in emerging markets due to their favorable safety profile and growing clinical evidence. They are also increasingly used in patients with contraindications to permanent metallic implants. The segment benefits from ongoing R&D investments focusing on material innovation and biocompatibility improvements. The rising awareness of minimally invasive, patient-friendly treatment options further fuels polymer stent adoption.

• By End-User

On the basis of end-user, the neurovascular stents market is segmented into hospitals, medical centers, ambulatory surgical centers, and others. The hospitals segment dominated the market with the largest share of 61.7% in 2024, owing to their advanced infrastructure, availability of trained neurointerventional specialists, and capacity to handle complex procedures. Hospitals also have the resources for advanced imaging systems required for precise stent deployment, making them the preferred choice for intracranial and carotid interventions. Moreover, hospitals often participate in clinical trials and research studies, supporting the adoption of innovative stents. Established reimbursement policies in hospital settings also make high-cost stent procedures financially viable for patients. The concentration of high-risk neurovascular cases in hospitals further strengthens this segment’s dominance.

Ambulatory surgical centers are expected to witness the fastest growth rate of 13.1% from 2025 to 2032, driven by the increasing trend of minimally invasive outpatient procedures and cost-effective treatment models. These centers offer quicker recovery times, lower procedural costs, and efficient patient throughput, making them attractive for less complex stent interventions. Technological advancements in stent delivery systems allow safe deployment in outpatient settings, supporting market expansion. In addition, the growing geriatric population and early diagnosis programs encourage the use of ambulatory centers for carotid and intracranial interventions. Increasing partnerships between stent manufacturers and outpatient facilities are also boosting segment growth.

Neurovascular Stents Market Regional Analysis

• North America dominated the neurovascular stents market with the largest revenue share of 43% in 2024, supported by a high prevalence of neurovascular diseases, advanced healthcare infrastructure, favorable reimbursement policies, and the presence of leading market players such as Stryker and Boston Scientific, driving substantial adoption in hospitals and specialized neurovascular center
• Patients and healthcare providers in the region highly value the effectiveness, safety, and precision offered by neurovascular stents, particularly intracranial and carotid artery stents, for the treatment of strokes and aneurysms
• This widespread adoption is further supported by the presence of leading market players such as Stryker, Boston Scientific, and Terumo Corporation, alongside strong investments in research, training programs for neurointerventional specialists, and advanced imaging technologies, establishing neurovascular stents as the preferred choice for hospitals and specialized medical centers

U.S. Neurovascular Stents Market Insight

The U.S. neurovascular stents market captured the largest revenue share of 78% in 2024 within North America, driven by the high prevalence of strokes, aneurysms, and carotid artery disease. Hospitals and specialized neurovascular centers are increasingly adopting minimally invasive stent procedures to improve patient outcomes and reduce recovery times. The strong presence of leading market players such as Stryker, Boston Scientific, and Terumo Corporation, alongside advanced imaging and catheterization technologies, further supports market growth. In addition, favorable reimbursement policies and well-established healthcare infrastructure facilitate wider access to neurovascular stents. Growing awareness among physicians and patients about the benefits of early intervention also propels market expansion.

Europe Neurovascular Stents Market Insight

The Europe neurovascular stents market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing incidences of strokes and aneurysms and rising awareness of minimally invasive treatment options. Healthcare providers are focusing on early diagnosis and intervention programs, encouraging the adoption of neurovascular stents in hospitals and medical centers. In addition, the presence of well-developed healthcare infrastructure and strong regulatory support facilitates the availability of advanced stent technologies. The market is witnessing notable growth across intracranial and carotid stent procedures, supported by both new and refurbished healthcare facilities. Furthermore, the adoption of advanced imaging and navigation systems enhances procedure accuracy, boosting confidence in stent-based treatments.

U.K. Neurovascular Stents Market Insight

The U.K. neurovascular stents market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising awareness of neurovascular disorders and increasing preference for minimally invasive interventions. Concerns regarding stroke and aneurysm risks are prompting hospitals and medical centers to integrate stent solutions into their treatment protocols. The U.K.’s advanced healthcare system, coupled with strong reimbursement policies and active physician training programs, continues to support market growth. Moreover, collaborations between stent manufacturers and healthcare providers for clinical trials and educational initiatives are stimulating adoption. The increasing number of neurointerventional procedures in both public and private hospitals further contributes to market expansion.

Germany Neurovascular Stents Market Insight

The Germany neurovascular stents market is expected to expand at a considerable CAGR during the forecast period, fueled by growing incidences of strokes and cerebral aneurysms and increasing patient awareness regarding minimally invasive treatment options. Germany’s robust healthcare infrastructure, emphasis on medical innovation, and adoption of advanced imaging technologies are key factors driving market growth. Hospitals and specialized centers prioritize stent interventions due to their proven safety and efficacy. In addition, government initiatives promoting preventive care and early diagnosis are accelerating the adoption of neurovascular stents. The trend toward personalized treatment approaches and improved post-operative care also supports market expansion.

Asia-Pacific Neurovascular Stents Market Insight

The Asia-Pacific neurovascular stents market is poised to grow at the fastest CAGR of 12.8% during the forecast period of 2025 to 2032, driven by increasing prevalence of neurovascular disorders, rising healthcare expenditure, and improving access to advanced treatment technologies in countries such as China, Japan, and India. Growing awareness among physicians and patients regarding minimally invasive interventions is accelerating stent adoption. In addition, government initiatives supporting early diagnosis, healthcare infrastructure development, and training programs for specialists are boosting market growth. The region’s expanding healthcare facilities and rising geriatric population further contribute to the demand for neurovascular stents.

Japan Neurovascular Stents Market Insight

The Japan neurovascular stents market is gaining momentum due to the country’s aging population, high prevalence of strokes and aneurysms, and well-established healthcare infrastructure. Japanese hospitals are increasingly integrating minimally invasive stent procedures to improve patient outcomes and reduce recovery periods. The presence of technologically advanced imaging and catheterization systems supports precise stent deployment. Moreover, the emphasis on early diagnosis and preventive care encourages the adoption of neurovascular stents in both public and private healthcare facilities. Collaborations between local manufacturers and international market leaders further fuel innovation and availability.

India Neurovascular Stents Market Insight

The India neurovascular stents market accounted for the largest revenue share in Asia-Pacific in 2024, attributed to the rising prevalence of neurovascular disorders, rapid urbanization, and increasing healthcare expenditure. Hospitals and specialized medical centers are adopting minimally invasive stent procedures to improve patient outcomes and reduce the burden of stroke-related disabilities. The push toward smart hospitals and advanced healthcare infrastructure, along with growing awareness among physicians and patients, is driving market growth. In addition, availability of cost-effective stent solutions and strong domestic manufacturing support further accelerates adoption. Early diagnosis programs and government initiatives for healthcare accessibility also contribute to the expanding market.

Neurovascular Stents Market Share

The neurovascular stents industry is primarily led by well-established companies, including:

• Stryker (U.S.)
• Boston Scientific Corporation (U.S.)
• Medtronic (Ireland)
• Terumo Corporation (Japan)
• Johnson & Johnson and its affiliates (U.S.)
• MicroPort Scientific Corporation (China)
• Penumbra, Inc. (U.S.)
• Acandis GmbH (Germany)
• Phenox GmbH (Germany)
• Cook (U.S.)
• Cordis Corporation (U.S.)
• W. L. Gore & Associates, Inc. (U.S.)
• Biotronik SE & Co. KG (Germany)
• Balt (France)
• Integer Holdings Corporation (U.S.)
• Micro Point Scientific, Inc. (U.S.)
• STENTYS SA (France)
• Blockade Medical LLC (U.S.)
• InspireMD, Inc. (U.S.)

What are the Recent Developments in Global Neurovascular Stents Market?

• In September 2025, India Approved the Supernova Stent Retriever for Ischemic Stroke Treatment. In a significant advancement for stroke care, India granted regulatory approval to the Supernova stent retriever, a device designed to remove blood clots causing ischemic strokes. Developed by a U.S.-based company, the device was trialed across 16 hospitals in India, including AIIMS Delhi, JIPMER Pondicherry, and CMRI Kolkata
• In July 2025, Boston Scientific introduced the Neuroform EZ Stent System, designed to provide enhanced flexibility and conformability, particularly in tortuous brain anatomy. The system incorporates Segmental Expansion technology for improved stent anchoring and stability, along with a simplified single-operator delivery system to facilitate preparation, delivery, and positioning
• In July 2025, Stryker announced the commercial launch of the Surpass Elite® Flow Diverter in the United States, South Korea, and Europe. This next-generation device combines an upgraded implant design with proprietary surface modifications for enhanced performance and reduced thrombin generation
• In June 2024, MicroVention, a subsidiary of Terumo Corporation, announced the U.S. commercial availability of the LVIS EVO Intraluminal Support Device. This device is the first fully visible coil-assist intracranial stent in the U.S. market, aimed at treating wide-neck intracranial aneurysms
• In December 2023, Imperative Care commenced a first-in-human clinical study for its neurovascular stent system, designed to require single antiplatelet therapy for patients undergoing stent-assisted treatment of wide-neck intracranial aneurysms

SKU-54622